(Q74485802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

F D Shi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

X F Bai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B G Xiao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P H van der Meide

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

H Link

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Neurological Sciences

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

1-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

Arthritis in myasthenia gravis

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis is mediated by IL-4 and antigen-specific T cell factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Peripheral deletion of antigen-reactive T cells in oral tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral and clinical responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Immunotherapy in neuromuscular disorders: current and future strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Optic neuritis, transverse myelitis, and anti-DNA antibodies nine years after thymectomy for myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Experimental autoimmune myasthenia gravis: cellular and humoral immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

The measurement of relative antibody affinity by ELISA using thiocyanate elution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

The transforming growth factor-beta family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

The anatomy of T-cell activation and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

The regulation of immune responses to dietary protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Myelination in rat brain: method of myelin isolation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Gamma-interferon is one of several direct B cell-maturing lymphokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Towards a comprehensive view of immunoglobulin class switching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

CD8 T-cells are not essential for the induction of "low-dose" oral tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Induction of Interferon-γ, Interleukin-4, and Transforming Growth Factor-β in Rats Orally Tolerized against Experimental Autoimmune Myasthenia Gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Treatment of autoimmune disease by oral tolerance to autoantigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

Antigen-specific immunotherapy of autoimmune disease: a commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900232-3

10.1016/S0022-510X(97)00232-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9562316%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference